Wake Forest University School of Medicine
Winston Salem, North Carolina, United States
Medical school in Winston-Salem, North Carolina
Bowman Gray Center for Medical Education, 475 Vine St, Winston-Salem, NC 27101
About Wake Forest University School of Medicine
Wake Forest University School of Medicine is the medical school of Wake Forest University, with two campuses located in Winston-Salem, North Carolina and Charlotte, North Carolina, United States.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Wake Forest University Health Sciences
48
Boston Scientific Corporation
12
Abbott Medical Devices
8
The George Washington University Biostatistics Center
7
Wake Forest University
7
MedImmune LLC
5
Celgene
4
Celgene Corporation
4
National Institute of Allergy and Infectious Diseases (NIAID)
4
Boehringer Ingelheim
3
Bristol-Myers Squibb
3
Clinical Trials at Wake Forest University School of Medicine
During the past decade, Wake Forest University School of Medicine conducted 102 clinical trials. In the 10-year time frame, 102 clinical trials started and 62 clinical trials were completed, i.e. on
average, 60.8% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 29 clinical trials were completed. i.e. 76.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment
Completed
750
An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex
Completed
660
Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.
Completed
A Multicenter Phase II/III, Placebo-Controlled Study of SNX-111 Administered Intrathecally to Cancer and AIDS Patients With Chronic Pain
Completed
100
The Safety and Effectiveness of RMP-7 Plus Amphotericin B in Patients With HIV and Cryptococcal Meningitis
Completed
A Comparison of Three Anti-HIV Drug Combinations Containing Saquinavir Soft Gelatin Capsules Used in HIV-1 Infected Patients
Completed
825
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Wake Forest University School of Medicine" #1 sponsor was "Wake Forest University Health Sciences" with 48 trials, followed by "Boston Scientific Corporation" with 12 trials
sponsored, "Abbott Medical Devices" with 8 trials sponsored, "The George Washington University Biostatistics Center" with 7 trials sponsored and "Wake Forest University"
with 7 trials sponsored. Other sponsors include 165 different institutions and
companies that sponsored additional 130 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Wake Forest University School of Medicine"
#1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 10 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 10 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 7 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 7 trials as a collaborator and "National Institute on Aging (NIA)" with 6 trials as a collaborator. Other collaborators include 105 different institutions and companies that were
collaborators in the rest 97 trials.
Clinical Trials Conditions at Wake Forest University School of Medicine
According to Clinical.Site data, the most researched conditions in "Wake Forest University School of Medicine" are
"HIV Infections" (13 trials), "Coronary Artery Disease" (6 trials), "Amyotrophic Lateral Sclerosis" (5 trials), "Breast Cancer" (5 trials) and "Obesity" (5 trials). Many other conditions were trialed in "Wake Forest University School of Medicine" in a lesser frequency.
Clinical Trials Intervention Types at Wake Forest University School of Medicine
Most popular intervention types in "Wake Forest University School of Medicine" are "Drug" (133 trials), "Device" (46 trials), "Other" (28 trials), "Behavioral" (21 trials) and "Biological" (15 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (42 trials), "placebo" (7 trials), "Zidovudine" (4 trials), "lenalidomide" (4 trials) and "Didanosine" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Wake Forest University School of Medicine
The vast majority of trials in "Wake Forest University School of Medicine" are
225 trials for "All" genders, 20 trials for "Female" genders and 6 trials for "Male" genders.
Clinical Trials Status at Wake Forest University School of Medicine
Currently, there are 49 active trials in "Wake Forest University School of Medicine".
4 are not yet recruiting,
24 are recruiting,
20 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 160 completed trials in Wake Forest University School of Medicine,
1 suspended trials,
and 28 terminated clinical trials to date.
Out of the total trials that were conducted in Wake Forest University School of Medicine, 10 "Phase 1"
clinical trials were conducted, 60 "Phase 2" clinical
trials and 79 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 8 trials, and there were
also 68 trials that are defined as “Not Applicable".